Patent details

Basic Information

Publication number:

92255

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP009909102

Legal Status:

Expired

Application number:

92255

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/13/819/001

Marketing Authorization Type:

Marketing Authorization Date:

13/03/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

17/07/2013

First Marketing Authorization date:

13/03/2013

Grant date:

17/09/2013

Activation date:

13/11/2020

Publication date:

17/09/2013

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

13/11/2025

SPC Extension Expiration:

13/11/2025

Rejection date:

Withdrawal date:

Owner

From:

17/07/2013

 

 

Name:

GRIFOLS THERAPEUTICS INC.

Address:

4101 RESEARCH COMMONS, 79 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC 27709, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

17/07/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

NOVOKHATNY Valery

Address:

United States (US)

2

Name:

JIANG Shan

Address:

United States (US)

3

Name:

COLANDENE James

Address:

United States (US)

4

Name:

ZIMMERMAN Thomas, P.

Address:

United States (US)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2020/13

Publication date:

07/12/2020

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

14/10/2024

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

OFFICE FREYLINGER S.A.

Filing date	Document type	Number of pages